Holley Announces Additional $25M Debt Paydown

Holley has utilized strong free cash flow to pay down $50 million in debt since September 2023Holley Inc. (NYSE:HLLY),a leader in automotive aftermarket performance solutions, todayannounced it paid down an additional

Holley has utilized strong free cash flow to pay down $50 million in debt since September 2023

Holley Inc. (NYSE:HLLY),a leader in automotive aftermarket performance solutions, todayannounced it paid down an additional $25 million in principal against its first lien term loan facility. This debt reduction against Holley’s first lien term loan facility was completed through opportunistic repurchases at a discount to par in November and December and were completed using cash on hand.

Combined with the $25 million paydown during September 2023, Holley has reduced the principal amount outstanding under its first lien term loan facility by $50 million since September 2023 allowing Holley to recognize up to an estimated $2 million in annualized net interest savings. Holley is committed to further reducing its leverage over the next 12 months.

“We are delivering our commitments and executing the strategy we outlined at the beginning of 2023 to improve financial flexibility and reduce leverage,” said Jesse Weaver, Chief Financial Officer, Holley. “The successful execution of these opportunistic repurchases is another key step forward for Holley. Looking ahead to 2024, our executive leadership team remains committed to prioritizing near-term cash flow for debt reduction.”

For more investor relations news, visit Holley’s website.

Total
0
Shares
Related Posts
Read More

Jaguar Health Announces Publication In Breast Cancer Research And Treatment Of Investigator-Initiated Phase 2 HALT-D Study Of Crofelemer For Prevention Of Chemotherapy-Induced Diarrhea In Breast Cancer Patients

Results of the study provide the first proof-of-concept data for potential use of crofelemer - a novel, oral, plant-based, non-opioid antidiarrheal prescription medication - in breast cancer patients SAN FRANCISCO, CA /

JAGX

Read More

NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What’s Behind The Surge?

The Canadian cannabis sector is witnessing a notable upswing, driven by recent developments including Tilray's (NASDAQ: TLRY) earnings report, Organigram's investor day (NASDAQ: OGI) and pivotal movements by Canopy Growth (NASDAQ:

ACB